Experts Answer Questions on the Management of Patients With T-Cell Lymphomas

In this podcast episode, Steven M. Horwitz, MD; Pamela B. Allen, MD, MSc; and Kerry Savage, MD, MSc, answer questions from an audience of healthcare professionals on topics related to the management of T-cell lymphomas, including:

• Use of brentuximab vedotin in ≤1% CD-30‒expressing lymphomas
• Strategies with JAK inhibition and epigenetic agents
• Allogeneic transplantation in cutaneous T-cell lymphoma

Presenters: 
Steven M. Horwitz MD
Member, Memorial Sloan Kettering Cancer Center 
Attending Physician, Memorial Hospital
Professor of Medicine, Weill Cornell Medical College 
New York, New York

Pamela B. Allen, MD, MSc
Assistant Professor
Department of Hematology/Oncology
Emory University, Winship Cancer Institute
The Emory Clinic
Atlanta, Georgia

Kerry Savage MD, MSc
Professor of Medicine 
University of British Columbia
Medical Oncologist
Division of Medical Oncology
BC Cancer 
Vancouver, British Columbia, Canada

Content for this program was supported by educational grants from Daiichi Sankyo; Kyowa Kirin, Inc.; and Seagen Inc. 

Link to the full program, including downloadable slides, expert commentary, and an on-demand webcast:
bit.ly/3ItqEOd

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.